标题
New Proteasome Inhibitors in Myeloma
作者
关键词
-
出版物
Current Hematologic Malignancy Reports
Volume 7, Issue 4, Pages 258-266
出版商
Springer Nature
发表日期
2012-10-18
DOI
10.1007/s11899-012-0141-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma
- (2012) R. Vij et al. BLOOD
- The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects
- (2012) M A Hurchla et al. LEUKEMIA
- Discovery and Development of Second-Generation Proteasome Inhibitors
- (2012) Christopher J. Kirk SEMINARS IN HEMATOLOGY
- The Immunoproteasome as a Target in Hematologic Malignancies
- (2012) Deborah J. Kuhn et al. SEMINARS IN HEMATOLOGY
- Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies
- (2011) E. C. Lee et al. CLINICAL CANCER RESEARCH
- In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells
- (2011) Dharminder Chauhan et al. CLINICAL CANCER RESEARCH
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
- (2011) B. C. Potts et al. CURRENT CANCER DRUG TARGETS
- Pharmacokinetics, Pharmacodynamics, Metabolism, Distribution, and Excretion of Carfilzomib in Rats
- (2011) J. Yang et al. DRUG METABOLISM AND DISPOSITION
- Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells In Vitro and In Vivo
- (2011) G. Dasmahapatra et al. MOLECULAR CANCER THERAPEUTICS
- A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma
- (2010) D. Chauhan et al. BLOOD
- Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia
- (2010) A. M. Roccaro et al. BLOOD
- Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
- (2010) S. Bringhen et al. BLOOD
- Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model
- (2010) Ajita V. Singh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
- (2010) E. Kupperman et al. CANCER RESEARCH
- Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
- (2010) Lawrence R. Dick et al. DRUG DISCOVERY TODAY
- Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma
- (2009) D. Chauhan et al. BLOOD
- The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan
- (2009) Eric Sanchez et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies
- (2009) O. A. O'Connor et al. CLINICAL CANCER RESEARCH
- Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)
- (2009) Han-Jie Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- The use of novel agents in the treatment of relapsed and refractory multiple myeloma
- (2009) J P Laubach et al. LEUKEMIA
- Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib
- (2009) Constantine S. Mitsiades et al. SEMINARS IN HEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now